XML 56 R55.htm IDEA: XBRL DOCUMENT v3.20.1
Investments Summarized Financial Information (Details) - NantOmics - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Schedule of Equity Method Investments [Line Items]    
Revenues $ 223 $ 1,746
Gross loss (1,163) (520)
Loss from operations (3,856) (6,884)
Impairment on equity investments 0 (12,265)
Net loss (1,360) (17,851)
Net loss attributable to NantOmics $ (1,329) $ (17,752)